Nasal NK/T-cell lymphoma: RT, CT, or both

Area of Science:

• Oncology
• Hematology
• Radiation Oncology

Background:

• Nasal type natural killer (NK)/T-cell lymphoma is an aggressive malignancy.
• Current treatment often involves combined modality therapy.

Purpose of the Study:

• To evaluate the efficacy of combined radiotherapy (RT) and chemotherapy (CT) in early-stage nasal type NK/T-cell lymphoma.
• To identify low-risk patient subgroups who may not require chemotherapy.

Main Methods:

• Retrospective analysis of patients with early-stage nasal type NK/T-cell lymphoma.
• Comparison of outcomes between patients treated with RT alone versus RT plus CT.

Main Results:

• Combined RT and CT significantly improved survival rates.
• A subset of low-risk patients treated with RT alone demonstrated comparable survival to those receiving CT.

Conclusions:

• Combined modality treatment is effective for early-stage nasal type NK/T-cell lymphoma.
• Chemotherapy can be safely omitted in select low-risk patients undergoing radiotherapy, potentially reducing treatment toxicity.